
OrganiGram Holdings Inc faces a notable decline as investor sentiment shifts, leading to a 4.03% drop in its stock price.
In the latest trading session, OrganiGram Holdings Inc (OGI.TO) experienced a significant downturn, closing at CA$1.43, down 4.03%. This decline comes despite the company's recent announcements of record revenues, raising questions about market sentiment and investor confidence in the cannabis sector.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
OrganiGram Holdings Inc
OGI.TO
OGI.TO
OrganiGram Holdings Inc
Market cap
$184.42M
52W high
$3.09
52W low
$1.20
1W change
-0.76%
Beta
1.85
Analyst Price Targets
Based on analyst covering OGI
Wall Street analysts forecast OGI stock price to rise 127.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.98
+127.5% Upside
Current Price
C$1.31
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on OGI's historical volatility
30-Day Vol
45.1%
Annualized
90-Day Vol
54.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.23 | C$1.06 – C$1.44 |
| 60 trading days | C$1.16 | C$0.93 – C$1.45 |
| 90 trading days | C$1.10 | C$0.84 – C$1.43 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should remain cautious as OrganiGram's stock faces downward pressure, even amid positive financial results. Understanding market reactions is crucial in navigating potential volatility.
4.03% Decline in One Trading Day
Despite impressive financial results, OrganiGram's stock dropped 4.03%, reflecting broader market concerns over the cannabis industry's future.
Bull case
OrganiGram's recent record revenue growth of 76% year-over-year shows strong operational performance. This could position the company well for a future recovery.
Bear case
The current decline in the stock highlights ongoing investor skepticism about the cannabis market's stability. If sentiment doesn't improve, we could see further price pressures.
Advertisement
Market Reaction to Positive Results
Despite OrganiGram announcing record fourth-quarter results with a 76% increase in gross revenue, the stock fell sharply. This suggests that investors may be more focused on broader concerns about the cannabis market than on the company's performance. For more details on their financials, check out the OGI.TO stock page.
Investor Sentiment and Future Outlook
The decline in OrganiGram's stock price reflects a cautious sentiment among investors regarding the cannabis sector's volatility. With a market cap of approximately CA$209.75 million, the stock's performance will be closely watched as the company navigates its growth strategy and market challenges. For ongoing updates, visit the OGI.TO stock page.
Advertisement
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


